Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             29 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Age- and Gender-Related Differences in Quality of Care and Outcomes of Patients Hospitalized With Heart Failure (from OPTIMIZE-HF) Fonarow, Gregg C.
2009
104 1 p. 107-115
9 p.
artikel
2 Bone Modifiers and the Quest to Slow Progression of Aortic Stenosis † † The views expressed in this editorial are solely those of the author and do not represent the opinions of the Uniformed Services of the Health Sciences or the United States Department of Defense. Goldstein, Robert E.
2009
104 1 p. 125-127
3 p.
artikel
3 Cardiogenic Shock Without Flow-Limiting Angiographic Coronary Artery Disease—(from the Should We Emergently Revascularize Occluded Coronary Arteries for Cardiogenic Shock Trial and Registry) French, John K.
2009
104 1 p. 24-28
5 p.
artikel
4 Contents 2009
104 1 p. A4-A6
nvt p.
artikel
5 Editorial Board 2009
104 1 p. A2-
1 p.
artikel
6 Flushing Profile of Extended-Release Niacin/Laropiprant Versus Gradually Titrated Niacin Extended-Release in Patients With Dyslipidemia With and Without Ischemic Cardiovascular Disease Maccubbin, Darbie
2009
104 1 p. 74-81
8 p.
artikel
7 Frequency of Elevated Troponin I and Diagnosis of Acute Myocardial Infarction Javed, Usman
2009
104 1 p. 9-13
5 p.
artikel
8 Gender Differences of Electrophysiological Characteristics in Focal Atrial Tachycardia Hu, Yu-Feng
2009
104 1 p. 97-100
4 p.
artikel
9 Impact of Family Hypertension History on Exercise-Induced Cardiac Remodeling Baggish, Aaron L.
2009
104 1 p. 101-106
6 p.
artikel
10 Impact of Optimal Medical Therapy With or Without Percutaneous Coronary Intervention on Long-Term Cardiovascular End Points in Patients With Stable Coronary Artery Disease (from the COURAGE Trial) Boden, William E.
2009
104 1 p. 1-4
4 p.
artikel
11 Influence of the Metabolic Syndrome Versus the Sum of Its Individual Components on Left Ventricular Geometry in Young Adults (from the Bogalusa Heart Study) Patel, Dharmendrakumar A.
2009
104 1 p. 69-73
5 p.
artikel
12 Long-Term Clinical Response of Cardiac Resynchronization After Chronic Right Ventricular Pacing Delnoy, Peter Paul H.M.
2009
104 1 p. 116-121
6 p.
artikel
13 Meta-Analysis of Adverse Cardiovascular Outcomes Associated With Antecedent Hypertension After Myocardial Infarction Chen, Guanmin
2009
104 1 p. 141-147
7 p.
artikel
14 Osteoporosis Treatment and Progression of Aortic Stenosis Skolnick, Adam H.
2009
104 1 p. 122-124
3 p.
artikel
15 Plasma N-Terminal Prohormone Brain Natriuretic Peptide as a Marker for Postoperative Cardiac Events in High-Risk Patients Undergoing Noncardiac Surgery Schutt, Robert Clark
2009
104 1 p. 137-140
4 p.
artikel
16 Prevalence and Clinical Characteristics of Right Ventricular Dysfunction in Transient Stress Cardiomyopathy Fitzgibbons, Timothy P.
2009
104 1 p. 133-136
4 p.
artikel
17 Prognostic Value of Hemoglobin A1C Levels in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention With Stent Implantation Lemesle, Gilles
2009
104 1 p. 41-45
5 p.
artikel
18 Rate of Acute ST-Elevation Myocardial Infarction in the United States from 1988 to 2004 (from the Nationwide Inpatient Sample) Movahed, Mohammad Reza
2009
104 1 p. 5-8
4 p.
artikel
19 Relation Between Inheritance of Cyanotic Congenital Heart Disease and Persistent Foramen Ovale Wilmshurst, Peter
2009
104 1 p. 148-149
2 p.
artikel
20 Relation of Genetic Polymorphisms in the Cytochrome P450 Gene With Clopidogrel Resistance After Drug-Eluting Stent Implantation in Koreans Lee, Jung Myung
2009
104 1 p. 46-51
6 p.
artikel
21 Relation of Multiple Inflammatory Biomarkers to Incident Atrial Fibrillation Schnabel, Renate B.
2009
104 1 p. 92-96
5 p.
artikel
22 Relation of Severe Coronary Artery Narrowing to Insulin or Thiazolidinedione Use in Patients With Type 2 Diabetes Mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study) Pop-Busui, Rodica
2009
104 1 p. 52-58
7 p.
artikel
23 Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein Cholesterol Levels With Rosuvastatin 40 mg Daily (from the ASTEROID Study) Wiviott, Stephen D.
2009
104 1 p. 29-35
7 p.
artikel
24 Safety and Tolerability of Dalcetrapib † † Conflicts of interest: Dr. Stein has received grants for studies of lipid-modifying agents, has received consulting fees and honoraria for professional input regarding agents to modify lipid profile, and/or has delivered lectures for the American Association for Clinical Chemistry, Washington, District of Columbia; Abbott Laboratories, Abbott Park, Illinois; AstraZeneca, Wilmington, Delaware; the United States Food and Drug Administration, Washington, District of Columbia; F. Hoffmann-La Roche Ltd., Basel, Switzerland; Isis Pharmaceuticals, Inc., Carlsbad, California; Merck & Co., Whitehouse Station, New Jersey; the National Lipid Association, Jacksonville, Florida; Novartis International AG, Basel Switzerland; Reliant Pharmaceuticals, Inc., Liberty Corner, New Jersey; Daiichi Sankyo Co., Ltd., Tokyo, Japan; Schering-Plough Corporation, Kenilworth, New Jersey; Takeda Pharmaceutical Company Ltd., Osaka, Japan; and Wyeth, Madison, New Jersey. Dr. Stroes has received consulting fees and honoraria from F. Hoffmann-La Roche Ltd. and Novartis International AG. Dr. Steiner has received consulting fees and honoraria from F. Hoffmann-La Roche Ltd.; Solvay, Brussels, Belgium; Ethypharm S.A., Saint-Cloud, France; and Merck Frosst Canada Ltd. (Kirkland, Quebec, Canada)/Schering-Plough Corporation. Dr. Buckley has received research grants from AstraZeneca; Merck Sharp & Dohme, Dublin, Ireland; and Pfizer, Inc., New York, New York. Dr. Buckley has received honoraria and consulting fees and/or delivered lectures for AstraZeneca; Bristol-Myers Squibb, New York, New York; F. Hoffmann-La Roche Ltd.; Novartis International AG; Pfizer, Inc.; and Sanofi-Aventis, Paris, France. Dr. Capponi has received consulting fees and honoraria from F. Hoffmann-La Roche Ltd. Dr. Burgess is an employee of Hoffmann-La Roche Inc., Nutley, New Jersey. Drs. Niesor and Kallend are employees of F. Hoffmann-La Roche Ltd. Dr. Kastelein has received research grants, honoraria, or consulting fees for professional input and/or has delivered lectures for Pfizer, Inc.; Merck Sharp & Dohme; F. Hoffmann-La Roche Ltd.; Novartis International AG; Isis Pharmaceuticals, Inc.; Kowa Pharmaceutical Company Ltd., Nagoya, Japan; Schering-Plough Corporation; and AstraZeneca. Stein, Evan A.
2009
104 1 p. 82-91
10 p.
artikel
25 Safety of Contrast in Stress Echocardiography in Stable Patients and in Patients With Suspected Acute Coronary Syndrome but Negative 12-Hour Troponin Anantharam, Brijesh
2009
104 1 p. 14-18
5 p.
artikel
26 The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease † † Published simultaneously in the Journal of Periodontology, the Official Journal of the American Academy of Periodontology. Friedewald, Vincent E.
2009
104 1 p. 59-68
10 p.
artikel
27 Timing and Duration of Myocardial Ischemia on Holter Monitoring Following Percutaneous Coronary Intervention and Their Association With Clinical Outcomes (a PROTECT-TIMI 30 Substudy Analysis) Gibson, C. Michael
2009
104 1 p. 36-40
5 p.
artikel
28 Usefulness of Left Ventricular Dyssynchrony After Acute Myocardial Infarction, Assessed by a Tagging Magnetic Resonance Image Derived Metric, as a Determinant of Ventricular Remodeling Chang, Sung-A.
2009
104 1 p. 19-23
5 p.
artikel
29 Ventricular Arrhythmia Following Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy Noseworthy, Peter A.
2009
104 1 p. 128-132
5 p.
artikel
                             29 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland